Details for: VYVANSE
Company: TAKEDA CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02439603 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 10 MG | CAPSULE | ORAL |
| 02490226 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 10 MG | TABLET (CHEWABLE) | ORAL |
| 02347156 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 20 MG | CAPSULE | ORAL |
| 02490234 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 20 MG | TABLET (CHEWABLE) | ORAL |
| 02322951 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 30 MG | CAPSULE | ORAL |
| 02490242 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 30 MG | TABLET (CHEWABLE) | ORAL |
| 02347164 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 40 MG | CAPSULE | ORAL |
| 02490250 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 40 MG | TABLET (CHEWABLE) | ORAL |
| 02490269 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 50 MG | TABLET (CHEWABLE) | ORAL |
| 02322978 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 50 MG | CAPSULE | ORAL |
| 02347172 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 60 MG | CAPSULE | ORAL |
| 02490277 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 60 MG | TABLET (CHEWABLE) | ORAL |
| 02458071 | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 70 MG | CAPSULE | ORAL |
Summary Reports
Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - Amphetamines - Suicidal Thoughts and Behaviours (Suicidality)
Regulatory Decision Summary
Summary Safety Review - Amphetamines - Suicidal Thoughts and Behaviours (Suicidality)
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.